Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
- PMID: 25478192
- PMCID: PMC4212714
- DOI: 10.1136/bmjresp-2014-000050
Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
Abstract
Background: Patients with pulmonary Mycobacterium avium complex (MAC) disease are often co-infected with various pathogenic microorganisms. This study aimed to determine the prevalence of co-infection with non-MAC pathogens and the risk factors associated with co-infection in patients with pulmonary MAC disease.
Methods: We retrospectively reviewed the patient characteristics, microbiological results and chest CT findings in 275 patients with pulmonary MAC who visited the Kyoto University Hospital from January 2001 to May 2013. We defined chronic pathogenic co-infection as the isolation of non-MAC pathogens from sputum samples taken on more than two visits that occurred at least 3 months apart.
Results: The participants were predominantly female (74.5%) and infected with M. avium (75.6%). Chronic co-infection with any pathogen was observed in 124 patients (45.1%). Methicillin-sensitive Staphylococcus aureus (MSSA; n=64), Pseudomonas aeruginosa (n=35) and Aspergillus spp (n=18) were the most prevalent pathogens. The adjusted factors were chronic obstructive pulmonary disease (COPD; OR=4.2, 95% CI 1.6 to 13.1) and pulmonary M. intracellulare disease (OR=2.2, 95% CI 1.1 to 4.4) in chronic co-infections; COPD (OR=4.2, 95% CI 2.1 to 31.4), long duration of MAC disease (OR=2.2, 95% CI 1.2 to 4.4) and nodules (OR=3.5, 95% CI 1.2 to 13.2) in chronic MSSA co-infection; COPD (OR=7.5, 95% CI 2.1 to 31.4) and lower lobe involvement (OR=9.9, 95% CI 2.0 to 90.6) in chronic P. aeruginosa co-infection; and use of systemic corticosteroids (OR=7.1, 95% CI 1.2 to 50.9) and pulmonary M. intracellulare disease (OR=4.0, 95% CI 1.1 to 14.5) in chronic Aspergillus spp co-infection.
Conclusions: Patients with pulmonary MAC disease frequently had chronic co-infections with pathogenic microorganisms such as MSSA, P. aeruginosa and Aspergillus. The risk factors for chronic co-infection were COPD and pulmonary M. intracellulare disease.
Keywords: Atypical Mycobacterial Infection; Bacterial Infection; Bronchiectasis; Respiratory Infection.
Figures

Similar articles
-
[Strategies for Mycobacterium avium complex infection control in Japan: how do they improve the present situation?].Kekkaku. 2013 Mar;88(3):355-71. Kekkaku. 2013. PMID: 23672176 Japanese.
-
[Non-tuberculous mycobacteriosis. What has been coming out].Kekkaku. 2011 Feb;86(2):113-25. Kekkaku. 2011. PMID: 21404655 Japanese.
-
Impact of chronic co-infection in pulmonary Mycobacterium avium complex disease after treatment initiation.BMC Pulm Med. 2022 Apr 25;22(1):157. doi: 10.1186/s12890-022-01947-7. BMC Pulm Med. 2022. PMID: 35468795 Free PMC article.
-
Exploring Potential COPD Immunosuppression Pathways Causing Increased Susceptibility for MAC Infections among COPD Patients.Clin Pract. 2021 Sep 9;11(3):619-630. doi: 10.3390/clinpract11030077. Clin Pract. 2021. PMID: 34563006 Free PMC article. Review.
-
[Treatment of non-tuberculous pulmonary mycobacteriosis].Kekkaku. 2006 Jan;81(1):35-50. Kekkaku. 2006. PMID: 16479999 Review. Japanese.
Cited by
-
Exploring the Association of Bacterial Coinfections with Clinical Characteristics of Patients with Nontuberculous Mycobacterial Pulmonary Disease.Tuberc Respir Dis (Seoul). 2024 Oct;87(4):505-513. doi: 10.4046/trd.2024.0003. Epub 2024 Apr 30. Tuberc Respir Dis (Seoul). 2024. PMID: 39362831 Free PMC article.
-
Co-infection with Nocardia spp. in a patient with Mycobacterium avium complex pulmonary disease: A case report.Respirol Case Rep. 2022 Sep 7;10(10):e01036. doi: 10.1002/rcr2.1036. eCollection 2022 Oct. Respirol Case Rep. 2022. PMID: 36090022 Free PMC article.
-
Lower airway microbiota in patients with clinically suspected Mycobacterium avium complex lung disease.Heliyon. 2021 Jun 11;7(6):e07283. doi: 10.1016/j.heliyon.2021.e07283. eCollection 2021 Jun. Heliyon. 2021. PMID: 34179537 Free PMC article.
-
Aspergillus Species in Bronchiectasis: Challenges in the Cystic Fibrosis and Non-cystic Fibrosis Airways.Mycopathologia. 2018 Feb;183(1):45-59. doi: 10.1007/s11046-017-0143-7. Epub 2017 May 17. Mycopathologia. 2018. PMID: 28516246 Review.
-
Proposed Etiotypes for Chronic Obstructive Pulmonary Disease: Controversial Issues.Tuberc Respir Dis (Seoul). 2024 Jul;87(3):221-233. doi: 10.4046/trd.2023.0194. Epub 2024 Feb 6. Tuberc Respir Dis (Seoul). 2024. PMID: 38317417 Free PMC article.
References
-
- Morimoto K, Iwai K, Uchimura K, et al. . A steady increase in nontuberculous mycobacteriosis mortality and estimated prevalence in Japan. Ann Am Thorac Soc 2014;11:1–8 - PubMed
-
- Hayashi M, Takayanagi N, Kanauchi T, et al. . Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med 2012;185:575–83 - PubMed
-
- Koh WJ, Jeong BH, Jeon K, et al. . Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M. avium complex lung disease. Chest 2012;142:1482–8 - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous